Targeting CD46 for both adenocarcinoma and neuroendocrine prostate cancer-Reference-Cited by-同舟云学术

Targeting CD46 for both adenocarcinoma and neuroendocrine prostate cancer

Published:2018-09-06 Issue:17 Volume:3 Page:
ISSN:2379-3708
Container-title:JCI Insight
language:en
Short-container-title:

Author:

Su Yang,Liu Yue,Behrens Christopher R.,Bidlingmaier Scott,Lee Nam-Kyung,Aggarwal Rahul,Sherbenou Daniel W.,Burlingame Alma L.,Hann Byron C.,Simko Jeffry P.,Premasekharan Gayatri,Paris Pamela L.,Shuman Marc A.,Seo Youngho,Small Eric J.,Liu Bin

Funder

National Institutes of Health

UCSF prostate cancer program

SU2C

Dr. Marian and Sheldon G. Adelson Medical Research Foundation

Publisher

American Society for Clinical Investigation

Subject

General Medicine

Link

https://insight.jci.org/articles/view/121497/files/pdf

Reference71 articles.

1. Abiraterone in metastatic prostate cancer;Ryan;N Engl J Med,2013

2. Abiraterone in Metastatic Prostate Cancer without Previous Chemotherapy

3. Abiraterone acetatefor the treatment of prostate cancer

4. Targeted MET Inhibition in Castration-Resistant Prostate Cancer: A Randomized Phase II Study and Biomarker Analysis with Rilotumumab plus Mitoxantrone and Prednisone

5. Antitumour activity of abiraterone acetate against metastatic castration-resistant prostate cancer progressing after docetaxel and enzalutamide (MDV3100)

Cited by 51 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Expression and prognosis of DSG-2, CXADR, CD46 in head and neck squamous cell carcinoma;Pathology - Research and Practice;2024-10

2. 3D small-scale dosimetry and tumor control of 225Ac radiopharmaceuticals for prostate cancer;Scientific Reports;2024-08-27

3. Feasibility study of ADCs targeting TROP-2, HER2, and CD46 in Ductal Adenocarcinoma and Intraductal Carcinoma of the prostate;World Journal of Urology;2024-07-11

4. The complement regulatory protein CD46 serves as a novel biomarker for cervical cancer diagnosis and prognosis evaluation;Frontiers in Immunology;2024-06-11

5. PBX1 as a novel master regulator in cancer: Its regulation, molecular biology, and therapeutic applications;Biochimica et Biophysica Acta (BBA) - Reviews on Cancer;2024-03